Download App

Log in to access Online Inquiry
Company Overview More
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital’s blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
CEO: Simon, Christopher A.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > HAE Haemonetics > Detailed Quotes

HAE Haemonetics

58.340+0.740+1.28%
Trading Session 05/17 10:21 ET
High
58.940
Open
58.440
Turnover
1.84M
Low
57.420
Pre Close
57.600
Volume
31.64K
Market Cap
2.98B
P/E(TTM)
69.45
52wk High
75.340
Shares
51.11M
P/E(Static)
69.45
52wk Low
43.500
Float Cap
2.96B
Bid/Ask %
-20.00%
Historical High
142.110
Shs Float
50.81M
Volume Ratio
0.34
Historical Low
6.344
Dividend TTM
--
Div Yield TTM
2200
P/B
3.98
Dividend LFY
--
Div Yield LFY
3771.00%
Turnover Ratio
0.06%
Amplitude
2.64%
Avg Price
58.108
Lot Size
1
Float Cap
2.96B
Bid/Ask %
-20.00%
Historical High
142.110
Shs Float
50.81M
Volume Ratio
0.34
Historical Low
6.344
Dividend TTM
--
P/B
3.98
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
2.64%
Avg Price
58.108
Lot Size
1
Price Forecast

No Data

News

Comment